Results 181 to 190 of about 23,220 (218)
Some of the next articles are maybe not open access.
The Genomics of Bronchopulmonary Dysplasia
NeoReviews, 2006Bronchopulmonary dysplasia continues to be a major cause of neonatal morbidity, despite significant progress in the treatment of preterm neonates. The cause is multifactorial, with prematurity as the primary culprit and other factors including ventilator-induced lung injury, exposure to oxygen, and inflammation. Recent studies in twins show that 53% of
Vineet, Bhandari, Jeffrey R, Gruen
openaire +2 more sources
Respiratory Care, 2009
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease that results from complications related to the lung injury during the treatment of respiratory distress syndrome, or develops in older infants when abnormal lung growth occurs.
openaire +2 more sources
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease that results from complications related to the lung injury during the treatment of respiratory distress syndrome, or develops in older infants when abnormal lung growth occurs.
openaire +2 more sources
Clinics in Chest Medicine
Bronchopulmonary dysplasia (BPD) is a chronic lung disease, associated with premature birth, that arises during the infantile period. It is an evolving disease process with an unchanged incidence due to advancements in neonatal care which allow for the survival of premature infants of lower gestational ages and birth weights.
Katelyn G, Enzer +2 more
openaire +2 more sources
Bronchopulmonary dysplasia (BPD) is a chronic lung disease, associated with premature birth, that arises during the infantile period. It is an evolving disease process with an unchanged incidence due to advancements in neonatal care which allow for the survival of premature infants of lower gestational ages and birth weights.
Katelyn G, Enzer +2 more
openaire +2 more sources
Biomarkers in Bronchopulmonary Dysplasia
Paediatric Respiratory Reviews, 2013Bronchopulmonary dysplasia (BPD) is a complex disorder secondary to gene-environment interactions, and is the commonest chronic lung disease in infancy. There is no specific or effective treatment available to date for BPD. Since the aetiopathogenesis of BPD is multifactorial, involving diverse molecular signaling pathways, a variety of biomarkers ...
Anita, Bhandari, Vineet, Bhandari
openaire +2 more sources
Pediatrics, 1982
In their detailed study of the long-term survivors of bronchopulmonary dysplasia (BPD) Smyth and colleagues1 contrast their findings of a high incidence of abnormal pulmonary function in early childhood with the commonly held view that pulmonary function becomes normal in most children surviving BPD.2 However, they do not give us detailed parameters of
openaire +2 more sources
In their detailed study of the long-term survivors of bronchopulmonary dysplasia (BPD) Smyth and colleagues1 contrast their findings of a high incidence of abnormal pulmonary function in early childhood with the commonly held view that pulmonary function becomes normal in most children surviving BPD.2 However, they do not give us detailed parameters of
openaire +2 more sources
The Management of Bronchopulmonary Dysplasia
Clinics in Perinatology, 1987After presentation of the actual knowledge concerning the pathophysiology of bronchopulmonary dysplasia, the prevention and the management of the disease are discussed. Techniques of ventilation, weaning procedures and prescription of drugs are also analyzed.
P, Monin, P, Vert
openaire +2 more sources
Understanding Bronchopulmonary Dysplasia
Archives of Pediatrics & Adolescent Medicine, 1986The term bronchopulmonary dysplasia (BPD) was initially introduced to describe chronic pulmonary changes that occurred in certain premature infants following respiratory distress syndrome (RDS). 1 Subsequently, BPD has been recognized as a sequela of other forms of severe lung disease in newborn infants.
openaire +2 more sources
Nutrition and bronchopulmonary dysplasia
The Journal of Maternal-Fetal & Neonatal Medicine, 2012We aimed to assess the current knowledge on the nutritional management of preterm infants at risk of developing bronchopulmonary dysplasia (BPD) or with BPD. We considered the evidence supporting the actual fluid and energy intake, proteins, lipids, and electrolytes requirement, and need for other nutrients in preterm infant at risk of developing BPD ...
DANI, CARLO, C. Poggi
openaire +3 more sources
Inflammation and bronchopulmonary dysplasia
Seminars in Neonatology, 2003Pulmonary inflammation is a key feature in the pathogenesis of bronchopulmonary dysplasia (BPD). This inflammatory process, induced by multiple risk factors, is characterized by the presence of inflammatory cells, cytokines and an arsenal of additional humoral mediators in the airways and pulmonary tissue of preterm infants with the condition.
openaire +2 more sources
Prevention of bronchopulmonary dysplasia
Current Opinion in Pediatrics, 2001The clinical syndrome of bronchopulmonary dysplasia (BPD) in preterm infants results primarily from an arrest of lung vascular and alveolar development. The most likely mediators are proinflammatory cytokines that are induced by antenatal exposure to infection, postnatal ventilation, and oxygen exposure.
A H, Jobe, M, Ikegami
openaire +2 more sources